{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:36:09Z","timestamp":1791318969613,"version":"4.3.1"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"8","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The recent development of hormonal therapy that blocks estrogen synthesis represents a major advance in the treatment of estrogen receptor\u2013positive breast cancer. However, cancer cells often acquire adaptations resulting in resistance. A recent report reveals that estrogen starvation\u2013induced apoptosis of breast cancer cells requires BIK, an apoptotic BH3-only protein located primarily at the endoplasmic reticulum (ER). Searching for novel partners that interact with BIK at the ER, we discovered that BIK selectively forms complex with the glucose-regulated protein GRP78\/BiP, a major ER chaperone with prosurvival properties naturally induced in the tumor microenvironment. GRP78 overexpression decreases apoptosis of 293T cells induced by ER-targeted BIK. For estrogen-dependent MCF-7\/BUS breast cancer cells, overexpression of GRP78 inhibits estrogen starvation\u2013induced BAX activation, mitochondrial permeability transition, and consequent apoptosis. Further, knockdown of endogenous GRP78 by small interfering RNA (siRNA) sensitizes MCF-7\/BUS cells to estrogen starvation\u2013induced apoptosis. This effect was substantially reduced when the expression of BIK was also reduced by siRNA. Our results provide the first evidence that GRP78 confers resistance to estrogen starvation\u2013induced apoptosis in human breast cancer cells via a novel mechanism mediated by BIK. These results further suggest that GRP78 expression level in the tumor cells may serve as a prognostic marker for responsiveness to hormonal therapy based on estrogen starvation and that combination therapy targeting GRP78 may enhance efficacy and reduce resistance. [Cancer Res 2007;67(8):3734\u201340]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4594","type":"journal-article","created":{"date-parts":[[2007,4,17]],"date-time":"2007-04-17T18:39:26Z","timestamp":1176835166000},"page":"3734-3740","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":272,"title":["GRP78\/BiP Inhibits Endoplasmic Reticulum BIK and Protects Human Breast Cancer Cells against Estrogen Starvation\u2013Induced Apoptosis"],"prefix":"10.1158","volume":"67","author":[{"given":"Yong","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, USC\/Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianze","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, USC\/Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, USC\/Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,4,17]]},"reference":[{"key":"2022061623200762300_B1","doi-asserted-by":"crossref","unstructured":"Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol\u20082005; 23: 1616\u201322.","DOI":"10.1200\/JCO.2005.10.036"},{"key":"2022061623200762300_B2","doi-asserted-by":"crossref","unstructured":"Clarke R, Leonessa F, Welch JN, Skaar TC. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev\u20082001; 53: 25\u201371.","DOI":"10.1016\/S0960-0760(00)00193-X"},{"key":"2022061623200762300_B3","doi-asserted-by":"crossref","unstructured":"Dowsett M, Nicholson RI, Pietras RJ. Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance. Breast Cancer Res Treat\u20082005; 93: S11\u20138.","DOI":"10.1007\/s10549-005-9037-3"},{"key":"2022061623200762300_B4","doi-asserted-by":"crossref","unstructured":"Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer\u20082003; 98: 1802\u201310.","DOI":"10.1002\/cncr.11745"},{"key":"2022061623200762300_B5","unstructured":"Thiantanawat A, Long BJ, Brodie AM. Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens. Cancer Res\u20082003; 63: 8037\u201350."},{"key":"2022061623200762300_B6","doi-asserted-by":"crossref","unstructured":"Cheng EH, Wei MC, Weiler S, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell\u20082001; 8: 705\u201311.","DOI":"10.1016\/S1097-2765(01)00320-3"},{"key":"2022061623200762300_B7","doi-asserted-by":"crossref","unstructured":"Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science\u20082001; 292: 727\u201330.","DOI":"10.1126\/science.1059108"},{"key":"2022061623200762300_B8","doi-asserted-by":"crossref","unstructured":"Diel P, Smolnikar K, Michna H. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down-regulation of BCL-2 than tamoxifen in MCF-7 cells. Breast Cancer Res Treat\u20081999; 58: 87\u201397.","DOI":"10.1023\/A:1006338123126"},{"key":"2022061623200762300_B9","doi-asserted-by":"crossref","unstructured":"Hur J, Chesnes J, Coser KR, et al. The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proc Natl Acad Sci U S A\u20082004; 101: 2351\u20136.","DOI":"10.1073\/pnas.0307337101"},{"key":"2022061623200762300_B10","doi-asserted-by":"crossref","unstructured":"Coser KR, Chesnes J, Hur J, Ray S, Isselbacher KJ, Shioda T. Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7\/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci U S A\u20082003; 100: 13994\u20139.","DOI":"10.1073\/pnas.2235866100"},{"key":"2022061623200762300_B11","doi-asserted-by":"crossref","unstructured":"Germain M, Mathai JP, Shore GC. BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria. J Biol Chem\u20082002; 277: 18053\u201360.","DOI":"10.1074\/jbc.M201235200"},{"key":"2022061623200762300_B12","doi-asserted-by":"crossref","unstructured":"Mathai JP, Germain M, Shore GC. BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J Biol Chem\u20082005; 280: 23829\u201336.","DOI":"10.1074\/jbc.M500800200"},{"key":"2022061623200762300_B13","doi-asserted-by":"crossref","unstructured":"Lee AS. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci\u20082001; 26: 504\u201310.","DOI":"10.1016\/S0968-0004(01)01908-9"},{"key":"2022061623200762300_B14","unstructured":"Hendershot LM. The ER function BiP is a master regulator of ER function. Mt Sinai J Med\u20082004; 71: 289\u201397."},{"key":"2022061623200762300_B15","doi-asserted-by":"crossref","unstructured":"Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr\u20081994; 4: 1\u201318.","DOI":"10.1615\/CritRevEukarGeneExpr.v4.i1.10"},{"key":"2022061623200762300_B16","doi-asserted-by":"crossref","unstructured":"Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest\u20082002; 110: 1389\u201398.","DOI":"10.1172\/JCI0216886"},{"key":"2022061623200762300_B17","doi-asserted-by":"crossref","unstructured":"Rutkowski DT, Arnold SM, Miller CN, et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol\u20082006; 4: e374.","DOI":"10.1371\/journal.pbio.0040374"},{"key":"2022061623200762300_B18","doi-asserted-by":"crossref","unstructured":"Gazit G, Lu J, Lee AS. De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat\u20081999; 54: 135\u201346.","DOI":"10.1023\/A:1006102411439"},{"key":"2022061623200762300_B19","doi-asserted-by":"crossref","unstructured":"Li J, Lee AS. Stress induction of GRP78\/BiP and its role in cancer. Curr Mol Med\u20082006; 6: 45\u201354.","DOI":"10.2174\/156652406775574523"},{"key":"2022061623200762300_B20","doi-asserted-by":"crossref","unstructured":"Fu Y, Lee AS. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol Ther\u20082006; 5: 741\u20134.","DOI":"10.4161\/cbt.5.7.2970"},{"key":"2022061623200762300_B21","doi-asserted-by":"crossref","unstructured":"Fernandez PM, Tabbara SO, Jacobs LK, et al. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat\u20082000; 59: 15\u201326.","DOI":"10.1023\/A:1006332011207"},{"key":"2022061623200762300_B22","doi-asserted-by":"crossref","unstructured":"Lee E, Nichols P, Spicer D, Groshen S, Yu MC, Lee AS. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res\u20082006; 66: 7849\u201353.","DOI":"10.1158\/0008-5472.CAN-06-1660"},{"key":"2022061623200762300_B23","doi-asserted-by":"crossref","unstructured":"Dong D, Ko B, Baumeister P, et al. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res\u20082005; 65: 5785\u201391.","DOI":"10.1158\/0008-5472.CAN-05-0754"},{"key":"2022061623200762300_B24","doi-asserted-by":"crossref","unstructured":"Rao RV, Peel A, Logvinova A, et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett\u20082002; 514: 122\u20138.","DOI":"10.1016\/S0014-5793(02)02289-5"},{"key":"2022061623200762300_B25","doi-asserted-by":"crossref","unstructured":"Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem\u20082003; 278: 20915\u201324.","DOI":"10.1074\/jbc.M212328200"},{"key":"2022061623200762300_B26","doi-asserted-by":"crossref","unstructured":"Ranganathan AC, Zhang L, Adam AP, Aguirre-Ghiso JA. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res\u20082006; 66: 1702\u201311.","DOI":"10.1158\/0008-5472.CAN-05-3092"},{"key":"2022061623200762300_B27","doi-asserted-by":"crossref","unstructured":"Ermakova SP, Kang BS, Choi BY, et al. (\u2212)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res\u20082006; 66: 9260\u20139.","DOI":"10.1158\/0008-5472.CAN-06-1586"},{"key":"2022061623200762300_B28","doi-asserted-by":"crossref","unstructured":"Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect\u20081995; 103: 113\u201322.","DOI":"10.1289\/ehp.95103s7113"},{"key":"2022061623200762300_B29","doi-asserted-by":"crossref","unstructured":"Zeng L, Lu M, Mori K, et al. ATF6 modulates SREBP2-mediated lipogenesis. EMBO J\u20082004; 23: 950\u20138.","DOI":"10.1038\/sj.emboj.7600106"},{"key":"2022061623200762300_B30","doi-asserted-by":"crossref","unstructured":"Lee AS. The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress. Methods\u20082005; 35: 373\u201381.","DOI":"10.1016\/j.ymeth.2004.10.010"},{"key":"2022061623200762300_B31","doi-asserted-by":"crossref","unstructured":"Wu F, Lee AS. Identification of AP-2 as an interactive target of Rb and a regulator of the G1\/S control element of the hamster histone H3.2 promoter. Nucleic Acids Res\u20081998; 26: 4837\u201345.","DOI":"10.1093\/nar\/26.21.4837"},{"key":"2022061623200762300_B32","doi-asserted-by":"crossref","unstructured":"Mandic A, Viktorsson K, Molin M, et al. Cisplatin induces the proapoptotic conformation of Bak in a \u03b4MEKK1-dependent manner. Mol Cell Biol\u20082001; 21: 3684\u201391.","DOI":"10.1128\/MCB.21.11.3684-3691.2001"},{"key":"2022061623200762300_B33","doi-asserted-by":"crossref","unstructured":"Tsutsumi S, Namba T, Tanaka KI, et al. Celecoxib up-regulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells. Oncogene\u20082006; 25: 1018\u201329.","DOI":"10.1038\/sj.onc.1209139"},{"key":"2022061623200762300_B34","doi-asserted-by":"crossref","unstructured":"Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene\u20082003; 22: 8608\u201318.","DOI":"10.1038\/sj.onc.1207108"},{"key":"2022061623200762300_B35","doi-asserted-by":"crossref","unstructured":"Scorrano L, Oakes SA, Opferman JT, et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science\u20082003; 300: 135\u20139.","DOI":"10.1126\/science.1081208"},{"key":"2022061623200762300_B36","doi-asserted-by":"crossref","unstructured":"Zong WX, Li C, Hatzivassiliou G, et al. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol\u20082003; 162: 59\u201369.","DOI":"10.1083\/jcb.200302084"},{"key":"2022061623200762300_B37","doi-asserted-by":"crossref","unstructured":"Germain M, Mathai JP, McBride HM, Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J\u20082005; 24: 1546\u201356.","DOI":"10.1038\/sj.emboj.7600592"},{"key":"2022061623200762300_B38","doi-asserted-by":"crossref","unstructured":"Arena V, Martini M, Luongo M, Capelli A, Larocca LM. Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer\u20082003; 38: 91\u20136.","DOI":"10.1002\/gcc.10245"},{"key":"2022061623200762300_B39","doi-asserted-by":"crossref","unstructured":"Davidson DJ, Haskell C, Majest S, et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res\u20082005; 65: 4663\u201372.","DOI":"10.1158\/0008-5472.CAN-04-3426"},{"key":"2022061623200762300_B40","doi-asserted-by":"crossref","unstructured":"Mitchell-Olds T, Knight CA. Evolution. Chaperones as buffering agents? Science\u20082002; 296: 2348\u20139.","DOI":"10.1126\/science.1073846"},{"key":"2022061623200762300_B41","doi-asserted-by":"crossref","unstructured":"Zhou Y, Lee AS. Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J Natl Cancer Inst\u20081998; 90: 381\u20138.","DOI":"10.1093\/jnci\/90.5.381"},{"key":"2022061623200762300_B42","doi-asserted-by":"crossref","unstructured":"Arap MA, Lahdenranta J, Mintz PJ, et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell\u20082004; 6: 275\u201384.","DOI":"10.1016\/j.ccr.2004.08.018"},{"key":"2022061623200762300_B43","doi-asserted-by":"crossref","unstructured":"Park HR, Tomida A, Sato S, et al. Effect on tumor cells of blocking survival response to glucose deprivation. J Natl Cancer Inst\u20082004; 96: 1300\u201310.","DOI":"10.1093\/jnci\/djh243"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/8\/3734\/2582191\/3734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/8\/3734\/2582191\/3734.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:30:54Z","timestamp":1655433054000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/8\/3734\/534999\/GRP78-BiP-Inhibits-Endoplasmic-Reticulum-BIK-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,15]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2007,4,17]]},"published-print":{"date-parts":[[2007,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4594","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,15]]}}}